[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biota Pharmaceutical (BOTA)

Biota Pharmaceutical (BOTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biota Pharmaceutical 2500 NORTHWINDS PARKWAY SUITE 100 ALPHARETTA GA 30009

www.biotapharma.com P: 301-770-3099

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Biota Pharmaceuticals, Inc., formerly known as Nabi Biopharmaceuticals, is an anti-infective drug development company with focus in respiratory diseases, particularly influenza. Registered drugs of the Company includes: Relenza (T), a neuraminidase inhibitor, zanamivir, subsequently marketed by GlaxoSmithKline; and, Inavir ( R ), an influenza antiviral, registered to Daiichi Sankyo. Biota Pharmaceuticals, Inc. is headquartered in Rockville, Maryland.

Key Statistics

Overview:

Market Capitalization, $K 61,430
Shares Outstanding, K 38,640
% of Insider Shareholders 3.30%
% of Institutional Shareholders 33.85%

Financials:

Annual Sales, $ 24,600 K
Annual Net Income, $ -19,100 K
Last Quarter Sales, $ 1,700 K
Last Quarter Net Income, $ -6,500 K

Growth:

1-Year Return -34.87%
3-Year Return -62.83%
5-Year Return -95.37%
5-Year Revenue Growth -29.73%
5-Year Earnings Growth -550.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 05/05/16
Earnings Per Share ttm -0.86
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -189.47%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 1.108 on 11/09/12
Dividend Payable Date 11/08/12
Dividend Payout Ratio 0.00%
Most Recent Split 1-6 on 11/09/12

BOTA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -46.76%
Return-on-Assets % -41.92%
Profit Margin % -77.64%
Debt/Equity 0.01
Price/Sales 3.06
Price/Cash Flow N/A
Price/Book 1.07
Book Value/Share 1.49
Interest Coverage 0.00
60-Month Beta 0.82
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.